Delegate Survey - EUCROF 2018

Thank you for your participation to the 4th European Conference on Clinical Research in Vienna.

EUCROF is committed to organise informative conferences bringing optimal value to all Clinical Research professionals. As a participant to the recent 4th conference, we value your feed-back giving us the opportunity to better meet or even exceed your expectations in the future.

Please take a couple of minutes to provide your perspective (anonymous) and use free text sections as extensively as you wish:

Question Title

* 1. To which stakeholder group do you belong?

Other (please specify)

Question Title

* 2. In which category did you join?

Question Title

* 3. Conference Organization

	Excellent	Good	Average	Poor	N/A
Date of the event (i.e. late February)	Date of the event (i.e. late February) Excellent	Date of the event (i.e. late February) Good	Date of the event (i.e. late February) Average	Date of the event (i.e. late February) Poor	Date of the event (i.e. late February) N/A
Conference Website	Conference Website Excellent	Conference Website Good	Conference Website Average	Conference Website Poor	Conference Website N/A
Registration process	Registration process Excellent	Registration process Good	Registration process Average	Registration process Poor	Registration process N/A
Accommodation	Accommodation Excellent	Accommodation Good	Accommodation Average	Accommodation Poor	Accommodation N/A
Logistic support before and during the conference	Logistic support before and during the conference Excellent	Logistic support before and during the conference Good	Logistic support before and during the conference Average	Logistic support before and during the conference Poor	Logistic support before and during the conference N/A
Suitability of the location	Suitability of the location Excellent	Suitability of the location Good	Suitability of the location Average	Suitability of the location Poor	Suitability of the location N/A
Catering	Catering Excellent	Catering Good	Catering Average	Catering Poor	Catering N/A
Networking opportunities	Networking opportunities Excellent	Networking opportunities Good	Networking opportunities Average	Networking opportunities Poor	Networking opportunities N/A
Social event (Monday evening)	Social event (Monday evening) Excellent	Social event (Monday evening) Good	Social event (Monday evening) Average	Social event (Monday evening) Poor	Social event (Monday evening) N/A
Staff/organisers	Staff/organisers Excellent	Staff/organisers Good	Staff/organisers Average	Staff/organisers Poor	Staff/organisers N/A

Question Title

* 4. Conference Programme

	Excellent	Good	Average	Poor	N/A
Business pertinence of topics?	Business pertinence of topics? Excellent	Business pertinence of topics? Good	Business pertinence of topics? Average	Business pertinence of topics? Poor	Business pertinence of topics? N/A
Quality of presentations?	Quality of presentations? Excellent	Quality of presentations? Good	Quality of presentations? Average	Quality of presentations? Poor	Quality of presentations? N/A
Conference format (plenary / parallel)	Conference format (plenary / parallel) Excellent	Conference format (plenary / parallel) Good	Conference format (plenary / parallel) Average	Conference format (plenary / parallel) Poor	Conference format (plenary / parallel) N/A

Question Title

* 5. Sessions
Would your time permit, please further evaluate the Sessions:

Monday
The Key Note speaker lecture - How Did This Happen?
Plenary session

	Excellent	Good	Average	Poor	N/A
Presentation content	Presentation content Excellent	Presentation content Good	Presentation content Average	Presentation content Poor	Presentation content N/A

Question Title

* The Clinical Trials Regulation
Plenary session

	Excellent	Good	Average	Poor	N/A
Presentation content	Presentation content Excellent	Presentation content Good	Presentation content Average	Presentation content Poor	Presentation content N/A
Session format	Session format Excellent	Session format Good	Session format Average	Session format Poor	Session format N/A

Question Title

* The gold sponsor lecture- Latest geographic trends in global industry Clinical trials: who is winning, who is losing?

	Excellent	Good	Average	Poor	N/A
Presentation content	Presentation content Excellent	Presentation content Good	Presentation content Average	Presentation content Poor	Presentation content N/A

Question Title

* The New addendum to GCP E6 (R2) & Operating models
Plenary session

	Excellent	Good	Average	Poor	N/A
Presentation content	Presentation content Excellent	Presentation content Good	Presentation content Average	Presentation content Poor	Presentation content N/A
Session format	Session format Excellent	Session format Good	Session format Average	Session format Poor	Session format N/A

Question Title

* Part 1 -Risk Based approaches in Clinical Trials
Plenary session

	Excellent	Good	Average	Poor	N/A
Presentation content	Presentation content Excellent	Presentation content Good	Presentation content Average	Presentation content Poor	Presentation content N/A
Session format	Session format Excellent	Session format Good	Session format Average	Session format Poor	Session format N/A

Question Title

* Part 2 - eTMF, eSource, Data Privacy...
Plenary session

	Excellent	Good	Average	Poor	N/A
Presentation content	Presentation content Excellent	Presentation content Good	Presentation content Average	Presentation content Poor	Presentation content N/A
Session format	Session format Excellent	Session format Good	Session format Average	Session format Poor	Session format N/A

Question Title

* Tuesday
e-Systems and Technical Solutions
Parallel session

	Excellent	Good	Average	Poor	N/A
Presentation content	Presentation content Excellent	Presentation content Good	Presentation content Average	Presentation content Poor	Presentation content N/A
Session format	Session format Excellent	Session format Good	Session format Average	Session format Poor	Session format N/A

Question Title

* Clinical Trials in Paediatric Population
Parallel session

	Excellent	Good	Average	Poor	N/A
Presentation content	Presentation content Excellent	Presentation content Good	Presentation content Average	Presentation content Poor	Presentation content N/A
Session format	Session format Excellent	Session format Good	Session format Average	Session format Poor	Session format N/A

Question Title

* EU Medical Device Regulation
Parallel session

	Excellent	Good	Average	Poor	N/A
Presentation content	Presentation content Excellent	Presentation content Good	Presentation content Average	Presentation content Poor	Presentation content N/A
Session format	Session format Excellent	Session format Good	Session format Average	Session format Poor	Session format N/A

Question Title

* Data Protection Regulation (GDPR) revamped
Parallel session

	Excellent	Good	Average	Poor	N/A
Presentation content	Presentation content Excellent	Presentation content Good	Presentation content Average	Presentation content Poor	Presentation content N/A
Session format	Session format Excellent	Session format Good	Session format Average	Session format Poor	Session format N/A

Question Title

* Post approval considerations
Plenary session

	Excellent	Good	Average	Poor	N/A
Presentation content	Presentation content Excellent	Presentation content Good	Presentation content Average	Presentation content Poor	Presentation content N/A
Session format	Session format Excellent	Session format Good	Session format Average	Session format Poor	Session format N/A

Question Title

* Brexit
Plenary session

	Excellent	Good	Average	Poor	N/A
Presentation content	Presentation content Excellent	Presentation content Good	Presentation content Average	Presentation content Poor	Presentation content N/A
Session format	Session format Excellent	Session format Good	Session format Average	Session format Poor	Session format N/A

Question Title

* Have you any preference for more panel discussions and/or parallel track sessions?

Question Title

* What are the topics that you would like to see covered during the next conference?

Question Title

* 6. B2B Meetings

	Excellent	Good	Average	Poor	N/A
Planning the meetings online	Planning the meetings online Excellent	Planning the meetings online Good	Planning the meetings online Average	Planning the meetings online Poor	Planning the meetings online N/A
Onsite organisation of meetings	Onsite organisation of meetings Excellent	Onsite organisation of meetings Good	Onsite organisation of meetings Average	Onsite organisation of meetings Poor	Onsite organisation of meetings N/A

Question Title

* Would you be interested in the B2Bs again during the next conference?

Yes

Question Title

* 7. Your overall conference experience

	Surely	Likely	Unlikely	Don´t know
Would you join again?	Would you join again? Surely	Would you join again? Likely	Would you join again? Unlikely	Would you join again? Don´t know
Would you recommend this event?	Would you recommend this event? Surely	Would you recommend this event? Likely	Would you recommend this event? Unlikely	Would you recommend this event? Don´t know

Question Title

* 1. To which stakeholder group do you belong?

Question Title

* 2. In which category did you join?

Question Title

* 3. Conference Organization

Question Title

* 4. Conference Programme

Question Title

* 5. SessionsWould your time permit, please further evaluate the Sessions:MondayThe Key Note speaker lecture - How Did This Happen?Plenary session

Question Title

* The Clinical Trials RegulationPlenary session

Question Title

* The gold sponsor lecture- Latest geographic trends in global industry Clinical trials: who is winning, who is losing?

Question Title

* The New addendum to GCP E6 (R2) & Operating modelsPlenary session

Question Title

* Part 1 -Risk Based approaches in Clinical TrialsPlenary session

Question Title

* Part 2 - eTMF, eSource, Data Privacy...Plenary session

Question Title

* Tuesday e-Systems and Technical SolutionsParallel session

Question Title

* Clinical Trials in Paediatric PopulationParallel session

Question Title

* EU Medical Device RegulationParallel session

Question Title

* Data Protection Regulation (GDPR) revampedParallel session

Question Title

* Post approval considerationsPlenary session

Question Title

* BrexitPlenary session

Question Title

* Have you any preference for more panel discussions and/or parallel track sessions?

Question Title

* What are the topics that you would like to see covered during the next conference?

Question Title

* 6. B2B Meetings

Question Title

* Would you be interested in the B2Bs again during the next conference?

Question Title

* 7. Your overall conference experience

Question Title

* 8. What would be the ideal frequency of the conference?

Question Title

* 9. Other comments? What should we improve in 2020....

* 5. Sessions
Would your time permit, please further evaluate the Sessions:

Monday
The Key Note speaker lecture - How Did This Happen?
Plenary session

* The Clinical Trials Regulation
Plenary session

* The New addendum to GCP E6 (R2) & Operating models
Plenary session

* Part 1 -Risk Based approaches in Clinical Trials
Plenary session

* Part 2 - eTMF, eSource, Data Privacy...
Plenary session

* Tuesday
e-Systems and Technical Solutions
Parallel session

* Clinical Trials in Paediatric Population
Parallel session

* EU Medical Device Regulation
Parallel session

* Data Protection Regulation (GDPR) revamped
Parallel session

* Post approval considerations
Plenary session

* Brexit
Plenary session